The US Food and Drug Administration has approved an at-home cervical cancer screening tool as an alternative to Pap smears by a gynecologist, the company behind the device said Friday.
May 10, 2025
0
16
The Trump administration quietly restored federal family planning money to Tennessee and Oklahoma, despite court rulings that the states weren't entitled to funds because they refused to provide women with information about ...
May 5, 2025
0
16
The first trial of an AI-powered chatbot designed to inform parents about the HPV vaccine has shown that it increases vaccine uptake and engagement with health professionals.
Apr 11, 2025
0
28
Menstrual blood has historically been overlooked in research—considered only to be a waste product.
Apr 9, 2025
0
16
At-home self-sampling cervical screening looks likely to be an option in the future. But scientists warn that steps must be taken to ensure that the offer of at-home sampling doesn't have a negative impact on cervical screening ...
Mar 31, 2025
0
7
When a person dies, clinicians often look at the cause of death to determine whether it could have been avoided, either by medical prevention such as vaccines or by treatments like antibiotics. These types of deaths are known ...
Mar 24, 2025
0
108
Results from the NRG Oncology GOG-0263 Phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for patients with early-stage, ...
Mar 17, 2025
0
15
The incidence of and mortality from cervical cancer are higher among rural-residing women versus their urban counterparts within the United States, according to a research letter published online March 3 in JAMA Network Open.
Mar 7, 2025
0
14
People with intellectual disabilities (ID) are significantly less likely to participate in population-based cancer screening than the general population, according to researchers from Radboudumc and the academic collaborative ...
Mar 4, 2025
0
18
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating advanced cervical cancer by establishing a five-month progression-free survival benchmark for evaluating ...
Feb 14, 2025
0
16
